BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

Venovo™ Venous Stent proven safe and effective in iliac and femoral veins FRANKLIN LAKES, N.J., March 14, 2019 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, tod... Devices, Interventional, FDA BD , Venovo, venous stent, venous occlusive disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news